Titelia

Funds holding LIGAND PHARMACEUTICALS INC

ISIN US53220K1732 · United States · LEI 5493008K7TB0IKP37H79

Fund holders
3
Of which ETFs
1 2 other funds
Value held
2.2K $
Share of capital
0.1 % of 19.9M shares on Aug 4, 2026

This issuer has other securities : Ligand Pharmaceuticals Inc (US53220K5048), LIGAND PHARMACEUTICALS INC (US53220K1997), LIGAND PHARMACEUTICALS INC (US53220K1815), LIGAND PHARMACEUTICALS INC (US53220K2151)

FundSharesValueWeight in fundShare of capital
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 26,0872K $0.13 %as of Feb 28, 2026 ↗
Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust 1,530114.8 $0.01 %as of Feb 28, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 1,518113.9 $0.01 %as of Feb 28, 2026 ↗

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q23029,1350.0 %
2026Q13029,1350.0 %
2025Q43029,1350.0 %
2025Q33029,1350.0 %
2025Q23029,1350.0 %
2025Q13029,1350.0 %
2024Q43029,1350.0 %
2024Q33029,1350.0 %
2024Q23029,1350.0 %
2024Q13029,1350.0 %
2023Q4329,135

Funds holding the debt of LIGAND PHARMACEUTICALS INC

36 funds declare 36 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.

FundBond linesValue
Columbia Convertible Securities Fund112.1M $as of Feb 28, 2026
iShares Convertible Bond ETF110.6M $as of Apr 30, 2026
Virtus Income & Growth Fund17.3M $as of Mar 31, 2026
Virtus Convertible Fund17.1M $as of Mar 31, 2026
Calamos Market Neutral Income Fund16.7M $as of Apr 30, 2026
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF16.6M $as of Mar 31, 2026
Calamos Global Opportunities Fund13.7M $as of Apr 30, 2026
Fidelity Convertible Securities Fund13M $as of Feb 28, 2026
Calamos Convertible Fund13M $as of Apr 30, 2026
Invesco Convertible Securities Fund12.7M $as of Mar 31, 2026
WESTWOOD ALTERNATIVE INCOME FUND12.7M $as of Apr 30, 2026
Fidelity Strategic Dividend and Income Fund11.3M $as of Feb 28, 2026
Loomis Sayles Strategic Income Fund1826.1K $as of Mar 31, 2026
Voya Global Income & Growth Fund1742K $as of Feb 28, 2026
First Trust SSI Strategic Convertible Securities ETF1631.4K $as of Apr 30, 2026
Defensive Market Strategies Fund1419.4K $as of Mar 31, 2026
Harbor Ares Systematic Convertible Securities Fund1403K $as of Apr 30, 2026
Empower Core Strategies: Flexible Bond Fund1218.9K $as of Mar 31, 2026
1290 Loomis Sayles Multi-Asset Income Fund1195.8K $as of Apr 30, 2026
Empower Multi-Sector Bond Fund1170.5K $as of Mar 31, 2026
Miller Convertible Total Return ETF1167.9K $as of Apr 30, 2026
Loomis Sayles Fixed Income Fund1147.6K $as of Mar 31, 2026
PACE Alternative Strategies Investments1121.9K $as of Apr 30, 2026
TETON Convertible Securities Fund1121.2K $as of Mar 31, 2026
JNL Multi-Manager Alternative Fund1119.6K $as of Mar 31, 2026
Cite this page

Titelia. "Funds holding LIGAND PHARMACEUTICALS INC". https://titelia.com/en/stocks/ligand-pharmaceuticals-inc-US53220K1732